What are the top telehealth companies?
This blog post has been written by the person who has mapped the telehealth market in a clean and beautiful presentation
The telehealth industry has transformed from a pandemic necessity into a fundamental pillar of modern healthcare, with global market value reaching $161.64 billion in 2024 and projected to hit $791.04 billion by 2032.
Investment patterns reveal a maturing sector: $10.1 billion in venture funding flowed into digital health startups in 2024, with AI-enabled companies capturing 37% of total funding across 191 deals. The landscape is increasingly dominated by established platforms while early-stage innovation continues to reshape care delivery models.
And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.
Summary
The telehealth sector has reached unprecedented maturity in 2025, driven by established giants like Teladoc Health operating in 175+ countries while AI-enabled startups command 83% premium valuations. North America maintains 54% market dominance, though Asia-Pacific demonstrates the fastest growth trajectory with 27.6% CAGR projected through 2030.
Company Category | Leading Players | Market Position | Key Metrics |
---|---|---|---|
Global Market Leaders | Teladoc Health, Amwell, MDLIVE | Combined 90M+ members served globally | 175+ countries coverage |
AI Innovation Leaders | Abridge, Hippocratic AI, Babylon Health | $550M+ funding for AI solutions | 70% charting time reduction |
Direct-to-Consumer | Hims & Hers, PlushCare, Ro | Fastest-growing segment | 23% stock gains (Q2 2025) |
Regional Champions | Ping An Good Doctor (China), Practo (India) | Asia-Pacific market leaders | 31.5% regional market share |
Investment Activity | Andreessen Horowitz, General Catalyst | Leading transaction count | $34.4M avg AI deal size |
Market Technology | Zoom (36.16% market share), Epic, Cerner | Infrastructure dominance | 78.6% hospital adoption |
Growth Projections | 25-30% of US medical visits by 2026 | Mainstream adoption phase | 22.9% global CAGR |
Get a Clear, Visual
Overview of This Market
We've already structured this market in a clean, concise, and up-to-date presentation. If you don't have time to waste digging around, download it now.
DOWNLOAD THE DECKWhat are the names of the top telehealth companies globally right now?
The global telehealth landscape is dominated by several established platform providers operating at massive scale alongside emerging AI-powered innovators reshaping care delivery.
Teladoc Health leads the sector with operations spanning 175 countries and serving over 90 million members worldwide. The company processes 18.5 million visits annually across 450+ medical subspecialties in 40+ languages, making it the undisputed global leader by reach and volume. Amwell follows as the second-largest player, providing coverage to 90 million users through partnerships with 240+ health systems and 55 health plan partners.
MDLIVE, now owned by Evernorth, has established itself as a major force through its focus on affordability and accessibility, offering transparent pricing models that eliminate hidden fees. The platform serves both individual consumers and corporate clients with services spanning general health, dermatology, and mental health case management.
Zoom Commands 36.16% of the telehealth technology market share, having become ubiquitous across personal and professional healthcare communications since COVID-19. This represents the infrastructure layer that many healthcare providers rely upon for virtual consultations.
Emerging leaders include Babylon Health with its AI-driven approach to proactive healthcare, Hims & Hers Health showing explosive growth in direct-to-consumer telehealth, and PlushCare offering concierge-style telemedicine services. Regional powerhouses like Ping An Good Doctor dominate the Chinese market while Practo Technologies leads in India's rapidly expanding telehealth sector.
Which companies have attracted the most funding and how much did they raise in 2024 and so far in 2025?
The funding landscape in 2024-2025 reveals a concentration of capital flowing toward AI-enabled platforms and established players preparing for public market transitions.
Abridge captured the largest funding rounds with $550 million total across a $300 million Series E and $250 million Series D, positioning the company as the leading AI-powered clinical documentation platform. The company's technology reduces clinician charting time by up to 70%, addressing one of healthcare's most pressing efficiency challenges.
Hinge Health secured $437.3 million in funding while preparing for IPO, making it one of the most well-capitalized digital musculoskeletal care platforms. Innovaccer raised $275 million in Series F funding to expand its healthcare data platform capabilities, while Hippocratic AI banked $141 million in Series B to advance virtual nursing assistants powered by large language models.
The first half of 2025 showed continued momentum with $6.4 billion raised across digital health startups, up from $6 billion in the same period of 2024. AI-enabled companies captured a remarkable 62% of all funding in H1 2025, with average deal sizes of $34.4 million representing an 83% premium over non-AI competitors.
Eleven mega-deals exceeding $100 million occurred in the first half of 2025, with nine going to AI-enabled companies. This concentration demonstrates investor confidence in artificial intelligence as the primary driver of telehealth innovation and efficiency gains.

If you want fresh and clear data on this market, you can download our latest market pitch deck here
Who are the major investors behind these top telehealth companies and under what conditions did they invest?
The venture capital ecosystem supporting telehealth is dominated by mega-funds with deep healthcare expertise and strategic corporate investors seeking to integrate digital health capabilities.
Andreessen Horowitz (a16z) leads transaction count in digital health, having invested in companies spanning from Omada Health to Ribbon Health. Their investment thesis focuses on horizontal infrastructure plays and full-stack tech-enabled services, with typical check sizes ranging from $1-10 million for pre-seed and seed rounds.
General Catalyst has emerged as the second-most active investor, leveraging strategic partnerships with AWS to co-develop AI-driven healthcare solutions. Their portfolio companies benefit from enterprise-grade integration opportunities and access to cloud infrastructure resources that accelerate scaling.
Alumni Ventures has become the most active digital health VC by deal volume, focusing on diversified exposure across the sector. Other major players include Optum Ventures (the strategic arm of UnitedHealth Group), Connecticut Innovations for early-stage companies, and Rock Health as the dedicated digital health venture fund.
Investment conditions have evolved significantly, with 84% of deals now occurring in early-stage funding rounds (Seed through Series B). Investors prioritize companies demonstrating strong revenue models including subscription services, pay-per-visit structures, and employer partnerships. AI capabilities have become table stakes, with investors specifically seeking platforms offering virtual assistants, predictive analytics, and remote monitoring capabilities.
Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.
Typical deal structures now emphasize revenue-based financing and strategic partnerships over pure equity plays. The median deal size for AI startups commands premium valuations, reflecting investor confidence in technology-driven solutions to healthcare's systemic challenges.
Which countries or regions are seeing the most growth and concentration of leading telehealth companies?
Regional growth patterns reveal a global shift toward digital health adoption, with North America maintaining dominance while Asia-Pacific demonstrates the fastest expansion trajectory.
North America retains 54% of global market share, valued at $73.98 billion in 2024. The United States alone represents $60.15 billion in market value, projected to reach $467.80 billion by 2034 at a 22.77% CAGR. This dominance stems from robust healthcare infrastructure, high internet connectivity penetration, and favorable reimbursement policies including permanent Medicare telehealth flexibilities.
Asia-Pacific emerges as the fastest-growing region with 31.5% of global telehealth revenue and projections to reach $167.2 billion by 2030 at a 27.6% CAGR. China leads with Ping An Good Doctor dominating the Asian market, while India's Practo Technologies expands rapidly across underserved populations. Japan has recently accelerated adoption, with 2025 policy changes allowing first-time medical consultations via telehealth for non-emergency conditions.
Europe experienced a surprising 27% funding increase in 2024, reaching $2.8 billion despite a 29% decline in deal count. Germany's Digital Healthcare Act and EU-wide regulatory improvements have accelerated adoption of e-prescriptions and teleconsultations. The UK's investment in teledermatology and telepsychiatry has established the region as a key growth market.
Latin America shows robust potential with 20.5% projected CAGR from 2024-2030, driven by government initiatives in Brazil and Mexico to expand healthcare access in rural populations. The region's collaboration with global health tech companies is creating new opportunities for telehealth platform deployment.
The Market Pitch
Without the Noise
We have prepared a clean, beautiful and structured summary of this market, ideal if you want to get smart fast, or present it clearly.
DOWNLOADAre the major industry players or tech giants backing any of these top telehealth companies?
Big Tech companies have made strategic investments and partnerships across the telehealth ecosystem, integrating digital health capabilities into their broader platform strategies.
Microsoft has partnered extensively through its Healthcare cloud solutions and AI capabilities, working with companies like Epic and Cerner to integrate telehealth functionalities into existing electronic health record systems. Their Azure cloud infrastructure powers many telehealth platforms' scaling requirements.
Google Health leverages AI and data capabilities to support telehealth innovation, recently announcing new AI tools for mental health research and treatment. The company's investment in healthcare AI reached $7.20 billion in 2023, with projections suggesting $11.10 billion in 2024.
Amazon has integrated telehealth through Amazon One Medical, offering Prime members pay-per-visit telehealth options alongside traditional healthcare services. This strategic approach combines retail convenience with healthcare delivery, creating new hybrid care models.
Apple Health continues expanding digital health tools and telemedicine integration, particularly through Apple Watch health monitoring features and integration with major telehealth platforms for continuous patient monitoring.
Traditional healthcare organizations are also investing heavily. UnitedHealth Group through Optum Ventures has become one of the most active strategic investors, while major health systems like Cleveland Clinic and Mayo Clinic are building proprietary digital health ecosystems with AI and virtual care coordination tools.
Corporate partnerships have become increasingly important, with 21% of all digital health collaborations involving health systems partnerships. Insurance companies are integrating telehealth platforms directly into their benefit offerings, creating sustainable revenue models for telehealth providers.
Which telehealth startups have recently won awards or gained notable recognition?
The 2025 award season has highlighted companies advancing AI-powered healthcare solutions and innovative care delivery models across multiple categories.
AmplifyMD won the "Best Overall Telemedicine Platform" in the 2025 MedTech Breakthrough Awards, recognized for its comprehensive virtual care capabilities and user experience excellence. The platform's integration of multiple care delivery modes and provider network management set new industry standards.
AnswersNow received recognition as a leading virtual autism therapy platform in the MedTech Breakthrough Awards, addressing critical gaps in specialized pediatric care delivery. Their approach combines clinical expertise with technology-enabled therapy sessions accessible from home.
ClinicalKey AI won the "AI Innovation Award" in the 2025 MedTech Breakthrough Awards for the second consecutive year. Elsevier's platform combines trusted clinical content with conversational search powered by generative AI, supporting clinicians in delivering evidence-based patient care.
Iris Telehealth earned the 2025 Best in KLAS award, demonstrating exceptional performance in virtual care platforms based on user satisfaction and clinical outcomes. Their specialty focus on telestroke and telemedicine consulting has established new benchmarks for specialist care delivery.
The Utah Telehealth Network recognized Kelsie Green for AI implementation in stroke care, highlighting innovative applications of artificial intelligence in emergency telemedicine scenarios. This award demonstrates the expanding role of AI in critical care applications.
Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.
Several startups have been featured in Newsweek's World's Best Digital Health Companies 2024, representing 400 companies from 35 countries and highlighting the global scope of telehealth innovation.

If you need to-the-point data on this market, you can download our latest market pitch deck here
Which companies have introduced the most significant technological breakthroughs or R&D achievements in 2025?
Breakthrough technologies in 2025 have focused on AI-powered clinical workflows, predictive analytics, and seamless healthcare integration systems that address fundamental efficiency challenges.
Abridge leads AI documentation innovation with ambient intelligence technology that reduces clinician charting time by up to 70%. Their platform uses natural language processing to automatically generate clinical notes from patient-provider conversations, addressing physician burnout while improving documentation accuracy.
Cleveland Clinic achieved a remarkable 94% accuracy rate with its AI-powered virtual triage system across 13 emergency departments and 26 Express Care clinics. Their machine learning algorithms analyze patient symptoms and medical data to predict outcomes with unprecedented precision, revolutionizing emergency care delivery.
Hippocratic AI has developed sophisticated virtual nursing assistants capable of complex medical decision support, representing a significant advance in autonomous healthcare delivery. Their large language models are specifically trained for healthcare applications, offering 24/7 patient monitoring and intervention capabilities.
GE Healthcare unveiled LesionID™ Pro at the SNMMI 2025 meeting, featuring zero-click pre-processing to help physicians analyze tumor burden faster and more accurately. This theranostics advancement combines AI-powered imaging with radiopharmaceuticals for personalized cancer care.
Johns Hopkins has developed a sophisticated "video visit technical risk score" integrated into Epic electronic health records, using color-coded ratings to identify patients needing additional telehealth technology support. Their conversational AI through voice assistants achieved 32% better insulin medication adherence.
Mayo Clinic researchers developed an AI tool to detect surgical site infections from patient-submitted photos, enabling proactive wound monitoring and reducing post-operative complications through early intervention.
What breakthroughs are expected in 2026 and which companies are leading that innovation?
The 2026 innovation roadmap focuses on autonomous diagnostic systems, holographic telepresence, and predictive healthcare models that anticipate patient needs before symptoms manifest.
Autonomous diagnostic systems with minimal human intervention are expected to launch through partnerships between Teladoc Health and AI companies. These systems will conduct preliminary assessments, recommend treatment pathways, and escalate complex cases to human providers, fundamentally changing the efficiency of virtual care delivery.
Seamless EHR integration across all telehealth platforms represents a major breakthrough expected by late 2026. Epic, Cerner, and smaller platforms are developing universal interoperability standards that will eliminate data silos and enable comprehensive patient care coordination across multiple providers and systems.
Holographic telepresence technology is advancing through Microsoft's mixed reality partnerships with major health systems. These immersive medical consultations will enable complex procedures guidance, medical education, and specialist consultations with spatial computing capabilities.
Advanced AI assistants capable of complex medical decision support are being developed by Abridge, Hippocratic AI, and Google Health. These systems will integrate real-time patient monitoring, medical literature analysis, and treatment protocol optimization to support clinical decision-making.
Predictive intervention capabilities will expand significantly, with companies like Innovaccer developing data infrastructure platforms that analyze population health trends, individual risk factors, and environmental conditions to prevent health crises before they occur.
5G connectivity enabling high-quality remote consultations will become standard across major telehealth platforms, supporting real-time diagnostic imaging, AR/VR applications, and ultra-low latency interactions between patients and providers.
How much total investment was raised across the telehealth sector globally in 2024 and how much has been raised so far in 2025?
Investment data reveals a stabilizing telehealth market with strong capital flows toward AI-enabled platforms and mature companies preparing for public market transitions.
Global digital health funding reached $10.1 billion in 2024 across 497 deals in the United States, down slightly from $10.8 billion in 2023 but demonstrating market maturation rather than decline. The average deal size of $20.4 million approached pre-pandemic levels, indicating normalized valuation expectations.
AI-enabled companies captured 37% of total 2024 funding across 191 deals, with average valuations commanding significant premiums over traditional telehealth platforms. This concentration reflects investor confidence in artificial intelligence as the primary value driver for future healthcare efficiency.
The first half of 2025 generated $6.4 billion in venture funding, compared to $6 billion in H1 2024, representing steady growth momentum. AI-focused startups dominated with 62% of all funding, averaging $34.4 million per round—an 83% premium over non-AI peers.
Eleven mega-deals exceeding $100 million occurred in H1 2025, with nine targeting AI-enabled companies. This pattern suggests continued consolidation around technology-driven platforms capable of achieving significant scale and operational efficiency.
European markets experienced a 27% funding increase in 2024 despite declining deal counts, indicating larger average check sizes and growing confidence in European telehealth innovation. Asia-Pacific funding patterns show similar trends with increased capital allocation toward established platforms expanding regional coverage.
Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.
We've Already Mapped This Market
From key figures to models and players, everything's already in one structured and beautiful deck, ready to download.
DOWNLOAD
If you want actionable data about this market, you can download our latest market pitch deck here
Which telehealth companies are showing the strongest growth trajectory heading into 2026?
Growth trajectories entering 2026 favor companies with differentiated AI capabilities, proven revenue models, and strategic positioning in high-demand specialty areas.
Hims & Hers Health demonstrates explosive direct-to-consumer growth, with stock gains of 23% in Q2 2025 following partnerships with major pharmaceutical companies like Novo Nordisk for weight loss drug access. Their model combines telehealth consultations with direct medication delivery, capturing the growing personalized healthcare market.
Abridge maintains the strongest growth trajectory among AI companies, leveraging its $550 million funding to expand clinical documentation solutions across major health systems. Their 70% reduction in clinician charting time addresses critical physician burnout while generating measurable ROI for healthcare organizations.
Spring Health shows remarkable expansion covering 10 million lives through 450 employers and 27,000 partner groups. Their focus on evidence-based mental health outcomes with validated cost savings positions them for continued corporate adoption as employers prioritize behavioral health benefits.
Maven Clinic leads women's health telehealth with $300 million in funding and recognition in Time 100 Most Influential Companies. Their specialized focus on fertility, pregnancy, and women's health captures a historically underserved market with high engagement rates and strong clinical outcomes.
Ro (formerly Roman) expands rapidly in digital pharmacy and chronic condition management, recently partnering with major pharmaceutical companies to offer direct-to-consumer access to specialty medications. Their integrated approach combining telehealth, laboratory testing, and medication delivery creates comprehensive care pathways.
Regional growth leaders include Ping An Good Doctor in China and Practo Technologies in India, both positioned to capture Asia-Pacific's 27.6% CAGR growth through expanding smartphone penetration and government digital health initiatives.
What are some other notable traits or differentiators of the current top telehealth companies?
Leading telehealth companies distinguish themselves through specialized capabilities, strategic partnerships, and innovative service delivery models that address specific healthcare market inefficiencies.
Teladoc Health's global scale enables multilingual support across 40+ languages and 450+ medical subspecialties, creating network effects that smaller competitors cannot match. Their integration of chronic disease management, mental health support, and primary consultations within a single platform provides comprehensive care coordination.
Amwell's enterprise-grade scalability and white-label customization capabilities make it the preferred platform for large health systems and insurance companies seeking branded telehealth solutions. Their API integrations with major EHR systems optimize workflow efficiency while maintaining existing clinical processes.
Babylon Health leverages advanced AI symptom checkers providing instant insights and recommendations, positioning the platform as proactive rather than reactive healthcare. Their predictive analytics capabilities enable early intervention and population health management across global markets.
MDLIVE's transparent pricing model eliminates hidden fees and provides cost certainty for both individual patients and corporate clients. Their mobile-first approach ensures seamless access across devices while maintaining clinical quality standards.
Sesame Care operates on a membership-free, pay-per-visit model with transparent pricing published upfront. This approach appeals to uninsured patients and those seeking alternatives to traditional insurance-based healthcare delivery.
Zoom's dominance in telehealth infrastructure (36.16% market share) reflects the importance of reliable, user-friendly technology platforms that healthcare providers and patients can adopt quickly without extensive training requirements.
Curious about how money is made in this sector? Explore the most profitable business models in our sleek decks.
What can be expected in terms of investment trends and market dynamics for the telehealth industry in 2026?
The 2026 investment landscape will be characterized by continued AI focus, geographic diversification, regulatory stabilization, and increasing consolidation among smaller players seeking scale advantages.
AI-enabled investments will capture 60%+ of funding as companies demonstrate measurable improvements in clinical outcomes and operational efficiency. Investors will prioritize platforms showing clear ROI through reduced clinician workload, improved diagnostic accuracy, and enhanced patient engagement metrics.
Mega-deals exceeding $100 million will increase as companies reach maturity and prepare for public market transitions. The successful IPO performance of early telehealth leaders will open capital markets for well-positioned companies with proven revenue models and sustainable growth trajectories.
Geographic diversification will accelerate with increased investment in Asia-Pacific and European markets. The Asia-Pacific region's 27.6% CAGR and Europe's 27% funding growth in 2024 demonstrate strong investor confidence in international expansion opportunities.
Regulatory stabilization will provide clearer operating frameworks, with permanent telehealth policies expected to replace temporary pandemic-era flexibilities. This regulatory certainty will enable long-term strategic planning and sustained investment in telehealth infrastructure.
Consolidation activity will increase as smaller players seek partnerships or acquisitions to achieve necessary scale for competing with established platforms. Private equity firms will fuel this consolidation by combining legacy healthcare businesses with AI-native startups.
Priority investment areas will include proactive and preventive care solutions, chronic disease management platforms, mental health and behavioral services, AI-powered diagnostic tools, and interoperability solutions that enable seamless data integration across healthcare systems.
Market dynamics will favor companies demonstrating sustainable unit economics, proven clinical outcomes, and strategic partnerships with major health systems or insurance companies. The "grow at all costs" mentality will be replaced by emphasis on profitability and long-term value creation.
Conclusion
The telehealth industry has reached a critical inflection point where technology-driven efficiency gains meet mainstream healthcare adoption, creating unprecedented opportunities for investors and entrepreneurs alike.
With AI-enabled companies commanding 83% premium valuations and 25-30% of US medical visits projected to occur virtually by 2026, the sector's transformation from pandemic necessity to healthcare infrastructure is complete and irreversible.
Sources
- Healthline - Best Telehealth Companies of 2025
- Definitive Healthcare - Top Telehealth Companies by Market Share
- Fierce Healthcare - Digital Health Venture Funding Hit $10.1B in 2024
- Polaris Market Research - Telehealth Market Analysis
- Precedence Research - Telehealth Market Size and Trends
- Fortune Business Insights - Telehealth Market Report
- MedCity News - Digital Health Funding in H1 2025
- Netguru - AI in Telehealth Results from Top Hospitals
- MedTech Breakthrough Awards
- Elsevier - ClinicalKey AI Wins 2025 Award
- Grand View Research - Telehealth Market Analysis
- MarketsandMarkets - Telehealth Market Forecast
- Emerline - Telehealth Trends 2025
- Whereby - 5 Telehealth Predictions for 2025
- MobiHealthNews - Digital Health Funding Predictions 2025
Read more blog posts
-Telemedicine Business Model: Revenue Streams and Profitability Analysis
-Key Telemedicine Investors: Who's Funding the Future of Healthcare
-How Big is the Telemedicine Market: Size, Growth and Projections
-Telemedicine Funding Landscape: Investment Trends and Opportunities
-Telemedicine Investment Opportunities: Where Smart Money is Going
-Telemedicine Problems and Challenges: Industry Pain Points Revealed
-New Telemedicine Technology: Latest Innovations and Breakthroughs
-Telemedicine Trends 2025: What's Shaping the Future of Virtual Care
-Will Telemedicine Grow: Market Predictions and Growth Drivers